Erythroid abnormalities in rheumatoid arthritis: the role of erythropoietin. 1992

A F Remacha, and A Rodríguez-de la Serna, and F García-Dié, and C Geli, and C Díaz, and E Gimferrer
Hematology Department, Sant Pau Hospital, Autonomous University of Barcelona, Spain.

Erythroid alterations were studied in 136 patients with rheumatoid arthritis (RA). Anemia was present in 75 cases. A definite diagnosis was determined in 65. The most frequent anemia was that of chronic disease (ACD) (43 cases); 14 patients with ACD presented with moderate to severe anemia. Prevalence of deficiencies were also high (15 cases had iron deficiency anemia, IDA). Serum erythropoietin levels were different in patients with RA compared with a healthy control group (p < 0.00001). Serum erythropoietin was increased in ACD (49 +/- 28.8 U/l) with respect to both RA (38.6 +/- 12.7 U/l, p = 0.0036) and controls (18.2 +/- 7.6 U/l, p < 0.00001). Although hemoglobin (Hb) was similar in ACD and IDA, serum erythropoietin in ACD was lower than in IDA (p = 0.01). There was a negative relationship between Hb and serum erythropoietin in ACD (r = -0.42, p = 0.005). In conclusion, almost 50% of patients with RA have anemia and ACD is the most frequent. As serum erythropoietin in ACD is blunted, patients with moderate to severe ACD are possible candidates for erythropoietin treatment.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004921 Erythropoietin Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
D005260 Female Females
D005494 Folic Acid Deficiency A nutritional condition produced by a deficiency of FOLIC ACID in the diet. Many plant and animal tissues contain folic acid, abundant in green leafy vegetables, yeast, liver, and mushrooms but destroyed by long-term cooking. Alcohol interferes with its intermediate metabolism and absorption. Folic acid deficiency may develop in long-term anticonvulsant therapy or with use of oral contraceptives. This deficiency causes anemia, macrocytic anemia, and megaloblastic anemia. It is indistinguishable from vitamin B 12 deficiency in peripheral blood and bone marrow findings, but the neurologic lesions seen in B 12 deficiency do not occur. (Merck Manual, 16th ed) Deficiency, Folic Acid,Acid Deficiencies, Folic,Acid Deficiency, Folic,Deficiencies, Folic Acid,Folic Acid Deficiencies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

A F Remacha, and A Rodríguez-de la Serna, and F García-Dié, and C Geli, and C Díaz, and E Gimferrer
August 1978, American journal of diseases of children (1960),
A F Remacha, and A Rodríguez-de la Serna, and F García-Dié, and C Geli, and C Díaz, and E Gimferrer
January 1988, Contributions to nephrology,
A F Remacha, and A Rodríguez-de la Serna, and F García-Dié, and C Geli, and C Díaz, and E Gimferrer
March 1990, Clinical rheumatology,
A F Remacha, and A Rodríguez-de la Serna, and F García-Dié, and C Geli, and C Díaz, and E Gimferrer
July 1969, The Journal of laboratory and clinical medicine,
A F Remacha, and A Rodríguez-de la Serna, and F García-Dié, and C Geli, and C Díaz, and E Gimferrer
July 1968, Annals of the rheumatic diseases,
A F Remacha, and A Rodríguez-de la Serna, and F García-Dié, and C Geli, and C Díaz, and E Gimferrer
January 1972, Seminars in arthritis and rheumatism,
A F Remacha, and A Rodríguez-de la Serna, and F García-Dié, and C Geli, and C Díaz, and E Gimferrer
December 1997, The British journal of dermatology,
A F Remacha, and A Rodríguez-de la Serna, and F García-Dié, and C Geli, and C Díaz, and E Gimferrer
January 1984, Instructional course lectures,
A F Remacha, and A Rodríguez-de la Serna, and F García-Dié, and C Geli, and C Díaz, and E Gimferrer
September 1999, Lancet (London, England),
A F Remacha, and A Rodríguez-de la Serna, and F García-Dié, and C Geli, and C Díaz, and E Gimferrer
January 1980, Experimental hematology,
Copied contents to your clipboard!